Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Joshi

Showing results (381-390 of 455) with videos related to

Pageof 46
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Pediatric Blood & Cancer|May 15, 2021
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing countryJyoti Bajpai, Goutam Santosh Panda, Arun Chandrasekharan, et al.
Journal of Global Oncology|July 19, 2017
Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non-Small-Cell Lung CancerVijaya Raj Bhatt, Sanyo P D'Souza, Lynette M Smith, et al.
Chemotherapy Research and Practice|December 5, 2017
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?Amit Joshi, Vanita Noronha, Vijay M Patil, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 17, 2013
Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059Anup S Pathania, Amit Joshi, Suresh Kumar, et al.
South Asian Journal of Cancer|March 24, 2025
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained SettingsAmit Kumar, Akhil Kapoor, Vanita Noronha, et al.
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
A Novel Deep Learning-Based (3D U-Net Model) Automated Pulmonary Nodule Detection Tool for CT ImagingAbhishek Mahajan, Rajat Agarwal, Ujjwal Agarwal, et al.
ACS Nano|June 4, 2014
Au nanomatryoshkas as efficient near-infrared photothermal transducers for cancer treatment: benchmarking against nanoshellsCiceron Ayala-Orozco, Cordula Urban, Mark W Knight, et al.
The Lancet. Oncology|January 15, 2024
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trialJyoti Bajpai, Venkatesh Kapu, Sushmita Rath, et al.
Pageof 46

Showing results (381-390 of 455) with videos related to

Sort By:
Pageof 46
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 1, 2021
Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHDSumeet Mirgh, Anant Gokarn, Sachin Punatar, et al.
Pediatric Blood & Cancer|May 15, 2021
Adolescent-adult nonmetastatic Ewing sarcoma-Experience from a large developing countryJyoti Bajpai, Goutam Santosh Panda, Arun Chandrasekharan, et al.
Journal of Global Oncology|July 19, 2017
Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non-Small-Cell Lung CancerVijaya Raj Bhatt, Sanyo P D'Souza, Lynette M Smith, et al.
Chemotherapy Research and Practice|December 5, 2017
Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?Amit Joshi, Vanita Noronha, Vijay M Patil, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 17, 2013
Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059Anup S Pathania, Amit Joshi, Suresh Kumar, et al.
South Asian Journal of Cancer|March 24, 2025
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained SettingsAmit Kumar, Akhil Kapoor, Vanita Noronha, et al.
Indian Journal of Cancer|April 6, 2019
Bladder cancer demographics and outcome data from 2013 at a tertiary cancer hospital in IndiaGagan Prakash, Mahendra Pal, K Odaiyappan, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
A Novel Deep Learning-Based (3D U-Net Model) Automated Pulmonary Nodule Detection Tool for CT ImagingAbhishek Mahajan, Rajat Agarwal, Ujjwal Agarwal, et al.
ACS Nano|June 4, 2014
Au nanomatryoshkas as efficient near-infrared photothermal transducers for cancer treatment: benchmarking against nanoshellsCiceron Ayala-Orozco, Cordula Urban, Mark W Knight, et al.
The Lancet. Oncology|January 15, 2024
Low-dose versus standard-dose olanzapine with triple antiemetic therapy for prevention of highly emetogenic chemotherapy-induced nausea and vomiting in patients with solid tumours: a single-centre, open-label, non-inferiority, randomised, controlled, phase 3 trialJyoti Bajpai, Venkatesh Kapu, Sushmita Rath, et al.
Pageof 46